1. Home
  2. RDIB vs SENS Comparison

RDIB vs SENS Comparison

Compare RDIB & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDIB

Reading International Inc Class B

N/A

Current Price

$11.09

Market Cap

256.7M

ML Signal

N/A

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$5.60

Market Cap

308.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDIB
SENS
Founded
1937
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Industrial Machinery/Components
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
256.7M
308.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RDIB
SENS
Price
$11.09
$5.60
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$22.70
AVG Volume (30 Days)
6.8K
482.8K
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,389,000.00
Revenue This Year
N/A
$70.20
Revenue Next Year
$13.42
$59.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.85
52 Week Low
$6.70
$0.41
52 Week High
$17.40
$8.75

Technical Indicators

Market Signals
Indicator
RDIB
SENS
Relative Strength Index (RSI) 36.40 28.26
Support Level $8.95 $5.46
Resistance Level $12.51 $8.55
Average True Range (ATR) 0.55 0.49
MACD -0.27 -0.26
Stochastic Oscillator 3.18 7.85

Price Performance

Historical Comparison
RDIB
SENS

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: